DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 56.22 1.15%
S&P 500 2,086.24 25.22 1.22%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Near-Term Risks Could Affect AstraZeneca Investors

Heptares Takes Sosei Out Of Its Comfort Zone

Valeant Pharmaceuticals Buys Salix Pharmaceuticals in $14.5 Billion Megadeal

Forget MannKind Corporation; Here Are 3 Better Biotech Stocks

Although MannKind is launching Afrezza this year, our Motley Fool experts think these three stocks may be better buys.

Why Horizon Pharma PLC Stock Skyrocketed Today

Following a report that hedge funds are buying more shares, Horizon Pharmaceuticals is heading higher ahead of earnings that will be reported later this month.

Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

Heat Biologics Up on Immune-Oncology Deal with OncoSec - Analyst Blog

Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range

Actavis Barred from Selling Generic Pulmicort Respules - Analyst Blog

Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?

Pfizer has jumped into the promising field of cancer immunotherapy with both feet. Is this effort too little, too late for the pharma giant?
See More Articles...